MSF response to signing of EFTA-India trade agreement
March 12, 2024Geneva/Delhi, 12 March 2024: On 10 March 2024, it was announced that India and the European Free Trade Association (EFTA) signed a free trade agreement (FTA) they have been negotiating since 2006. Full text of agreement along with Annex and the Record...
Read more
MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease
November 7, 2023The World Health Organization’s (WHO) 2023 Global Tuberculosis (TB) Report released today shows that the estimated global incidence of TB in 2022 remains unacceptably high, including for the more difficult to treat form of this disease, drug-resistant TB (DR-TB). With...
Read more
MSF: TB test price reduction by Cepheid and Danaher is an important step in the right direction
September 19, 2023Cepheid and its parent company Danaher announced today that they are reducing the price of the Xpert MTB/RIF test for TB by 20 percent in high-TB-burden countries from US$9.98 to $7.97 per test. This reduction is a significant step, considering the...
Read more
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
September 12, 2023TB is curable but remains the world’s leading infectious disease killer 12 September 2023, Geneva/New York – Next week, world leaders meet for the second-ever global tuberculosis (TB) High-Level Meeting at the United Nations (UN) in New York, to endorse...
Read more
Transforming lives in Mozambique: surgical treatment for patients with neglected diseases in Mogovolas district
July 25, 2023Nampula, July 21 , 2023 – Médecins Sans Frontières/Doctors Without Borders (MSF) is collaborating with the District Services of Health, Women and Social Action in Mogovolas and the Provincial Services in Nampula, Mozambique, to deliver surgical treatment for hydrocele, one...
Read more
Gavi must do more as WHO/UNICEF estimates show slow childhood vaccination recovery
July 19, 2023Gavi should waive co-financing requirements for countries with fragile health systems or in humanitarian crises.Geneva, 18 July, 2023 — Today, Médecins Sans Frontières/Doctors Without Borders (MSF) again called on Gavi, the Vaccine Alliance to broaden “catch-up” vaccine coverage for unprotected...
Read more
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
July 18, 2023MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics. Recent deal offering controlled generics access in limited countries does not go...
Read more
TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
July 14, 2023Christophe Perrin, TB advocacy pharmacist, MSF Access Campaign "Today's announcement by the Stop TB Partnership/Global Drug Facility about a deal with pharmaceutical corporation Johnson & Johnson (J&J), for access to affordable generic versions of the lifesaving tuberculosis (TB) drug bedaquiline, offers...
Read more
MSF is disappointed with the inadequate outcome after nearly two years of discussions at the WTO
June 17, 2022Today, more than 20 months since India and South Africa first proposed a landmark intellectual property (IP) Waiver for COVID-19 medical tools at the World Trade Organization (WTO), governments have reached a decision at the 12th WTO Ministerial Conference in...
Read more
MSF responds to new WHO guidance recommending vastly shorter, improved and better-tolerated treatment for multi drug-resistant TB
May 4, 2022Geneva, 3rd May, 2022 - Médecins Sans Frontières/Doctors Without Borders (MSF) are pleased that, having shared the results of TB PRACTECAL, our clinical trial that found a new, safer and more effective six-month oral treatment regimen for multi drug-resistant tuberculosis (MDR-TB), the World...
Read more
Access to medicines: MSF applauds US’ leadership on waiving IP for COVID-19 vaccines
May 5, 2021NEW YORK — Doctors Without Borders/Médecins Sans Frontierès (MSF) applauds the Biden-Harris Administration’s decision to support waiving intellectual property protections for COVID-19 vaccines. Doing so will increase sufficient and timely access to these lifesaving medical tools as COVID-19 continues to ravage countries across the...
Read more
Access to medicines: Five people, five reasons we need to overcome monopolies on medicines
January 8, 2021Charles, Tobeka, Din, Nandita, and baby ‘Janey’. Four of these people have struggled for their lives. One of them has lost her life. All because pharma companies put profits before people. This is what can happen when companies get hold of patents and other...
Read more
